Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Francisco-Cruz

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Immunology|October 16, 2023
A novel [<sup>89</sup>Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancerAnder Puyalto, María Rodríguez-Remírez, Inés López, et al.
Oncoimmunology|August 13, 2024
Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin LymphomaJosé L Solórzano, Victoria Menéndez, Edwin Parra, et al.
Cancer Research|May 18, 2021
The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem CellsPrashant V Bommi, Charles M Bowen, Laura Reyes-Uribe, et al.
Journal for Immunotherapy of Cancer|May 1, 2020
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohortKyle G Mitchell, Lixia Diao, Tatiana Karpinets, et al.
Research Square|February 6, 2026
Tumor microenvironment changes after treatment with avelumab and immune- stimulating agent combinations in patients with advanced solid tumorsNejla Ozirmak Lermi, Mohamed A Gouda, Jibran Ahmed, et al.
Nature Medicine|November 14, 2018
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitisYinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Nature Medicine|November 28, 2018
Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitisYinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung CancerAlejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, et al.
Gut|July 10, 2020
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosaLaura Reyes-Uribe, Wenhui Wu, Ozkan Gelincik, et al.
Nature Medicine|February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trialTina Cascone, William N William, Annikka Weissferdt, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Immunology|October 16, 2023
A novel [<sup>89</sup>Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancerAnder Puyalto, María Rodríguez-Remírez, Inés López, et al.
Oncoimmunology|August 13, 2024
Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin LymphomaJosé L Solórzano, Victoria Menéndez, Edwin Parra, et al.
Cancer Research|May 18, 2021
The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem CellsPrashant V Bommi, Charles M Bowen, Laura Reyes-Uribe, et al.
Journal for Immunotherapy of Cancer|May 1, 2020
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohortKyle G Mitchell, Lixia Diao, Tatiana Karpinets, et al.
Research Square|February 6, 2026
Tumor microenvironment changes after treatment with avelumab and immune- stimulating agent combinations in patients with advanced solid tumorsNejla Ozirmak Lermi, Mohamed A Gouda, Jibran Ahmed, et al.
Nature Medicine|November 14, 2018
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitisYinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Nature Medicine|November 28, 2018
Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitisYinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung CancerAlejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, et al.
Gut|July 10, 2020
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosaLaura Reyes-Uribe, Wenhui Wu, Ozkan Gelincik, et al.
Nature Medicine|February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trialTina Cascone, William N William, Annikka Weissferdt, et al.
Pageof 2